18 Matching Annotations
  1. Jul 2024
  2. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Placental co-transcriptional activator Vestigial-like 1 (VGLL1) drives tumorigenesis via increasing transcription of proliferation and invasion genes
    1
    1. scibot 03 Jul 2024
      RRID:CVCL_1400

      DOI: 10.3389/fonc.2024.1403052

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11190739/
  3. Jan 2024
  4. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA
    1
    1. scibot 05 Jan 2024
      RRID:CVCL_1400

      DOI: 10.1038/s41467-023-44376-8

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10761696/
  5. Nov 2023
  6. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers
    1
    1. scibot 03 Nov 2023
      RRID:CVCL_1400

      DOI: 10.1158/1078-0432.CCR-23-0103

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10618648/
  7. Oct 2023
  8. 52.53.155.43 52.53.155.43
    ccr-23-0103-html.html
    1
    1. scibot 07 Oct 2023
      RRID:CVCL_1400

      DOI: 10.1158/1078-0432.ccr-23-0103

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/05abf3a0903b8473a428373dc7a2f791e1da90bb/ccr-23-0103-html.html
  9. Aug 2023
  10. 52.53.155.43 52.53.155.43
    ccr-23-0103-html.html
    1
    1. scibot 11 Aug 2023
      RRID:CVCL_1400

      DOI: 10.1158/1078-0432.ccr-23-0103

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/05abf3a0903b8473a428373dc7a2f791e1da90bb/ccr-23-0103-html.html
  11. Jul 2023
  12. 52.53.155.43 52.53.155.43
    ccr-23-0103-html.html
    1
    1. scibot 08 Jul 2023
      RRID:CVCL_1400

      DOI: 10.1158/1078-0432.ccr-23-0103

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/05abf3a0903b8473a428373dc7a2f791e1da90bb/ccr-23-0103-html.html
  13. Jun 2022
  14. aacrjournals.org aacrjournals.org
    Zenocutuzumab, a HER2xHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements
    1
    1. scibot 01 Jun 2022
      RRID:CVCL_1400

      DOI: 10.1158/2159-8290.CD-21-1119

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerdiscovery/article/12/5/1233/694554/Zenocutuzumab-a-HER2xHER3-Bispecific-Antibody-Is
  15. Dec 2021
  16. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with oncogenic NRG1 fusions
    1
    1. scibot 02 Dec 2021
      RRID:CVCL_1400

      DOI: 10.1158/1078-0432.CCR-20-3605

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @scibot

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC8172458/
  17. Aug 2021
  18. www.sciencedirect.com www.sciencedirect.com
    Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells
    1
    1. scibot 01 Aug 2021
      CVCL_1400

      DOI: 10.1016/j.cels.2019.11.001

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @ethanbadger

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2405471219303874
  19. May 2021
  20. link.springer.com link.springer.com
    Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
    1
    1. scibot 29 May 2021
      CVCL_1400

      DOI: 10.1007/s12282-021-01241-0

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @Naa003

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    link.springer.com/article/10.1007/s12282-021-01241-0
  21. www.sciencedirect.com www.sciencedirect.com
    Deciphering the signaling network of breast cancer improves drug sensitivity prediction
    1
    1. scibot 01 May 2021
      HTB-25

      DOI: 10.1016/j.cels.2021.04.002

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @Naa003

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400 RRIDCUR:Missing
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2405471221001113
  22. Oct 2020
  23. www.cell.com www.cell.com
    Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing
    1
    1. scibot 18 Oct 2020
      RRID:CVCL_1400

      DOI: 10.1016/j.chembiol.2020.07.011

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/cell-chemical-biology/abstract/S2451-9456(20)30284-1
  24. Sep 2020
  25. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity
    1
    1. scibot 30 Sep 2020
      RRID:CVCL_1400

      DOI: 10.1016/j.ebiom.2020.102996

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @evieth

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRID:CVCL_1400 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC7501074/
  26. mct.aacrjournals.org mct.aacrjournals.org
    ARX788, a Site-specific anti-HER2 Antibody Drug Conjugate, Demonstrates Potent and Selective Activity in HER2 Low and T-DM1 Resistant Breast and Gastric Cancers
    1
    1. scibot 11 Sep 2020
      RRID:CVCL_1400

      DOI: 10.1158/1535-7163.MCT-19-1004

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @Naa003

      SciCrunch record: RRID:CVCL_1400

      Curator comments: MDA-MB-175-VII cell line ATCC Cat# HTB-25

      What is this?
      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    mct.aacrjournals.org/content/19/9/1833
  27. onlinelibrary.wiley.com onlinelibrary.wiley.com
    FGF13 promotes metastasis of triple‐negative breast cancer
    1
    1. scibot 07 Sep 2020
      RRID:CVCL_1400

      DOI: 10.1002/ijc.32874

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @Naa003

      SciCrunch record: RRID:CVCL_1400

      What is this?
      RRIDCUR:Validated RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    onlinelibrary.wiley.com/doi/10.1002/ijc.32874
  28. Jan 2020
  29. www.sciencedirect.com www.sciencedirect.com
    Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy
    1
    1. scibot 13 Jan 2020
      RRID:CVCL_1400

      DOI: 10.1016/j.celrep.2019.08.105

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @ethanbadger

      SciCrunch record: RRID:CVCL_1400

      What is this?

      RRID:CVCL_1400 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124719311672
  30. www.sciencedirect.com www.sciencedirect.com
    Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion
    1
    1. scibot 13 Jan 2020
      RRID:CVCL_1400

      DOI: 10.1016/j.cmet.2019.01.020

      Resource: (ATCC Cat# HTB-25, RRID:CVCL_1400)

      Curator: @ethanbadger

      SciCrunch record: RRID:CVCL_1400

      What is this?

      RRID:CVCL_1400 RRIDCUR:Validated
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1550413119300208
  31. Nov 2018
  32. www.sciencedirect.com www.sciencedirect.com
    Unbiased Combinatorial Screening Identifies a Bispecific IgG1 that Potently Inhibits HER3 Signaling via HER2-Guided Ligand Blockade
    1
    1. scibot 05 Nov 2018
      RRID:CVCL_1400

      Resource used:

      (NCBI_Iran Cat# C432, RRID:CVCL_1400)

      SciCrunch record: RRID:CVCL_1400

      Alternate resolvers: SciCrunch xml N2T identifiers.org

      What is this?

      RRID:CVCL_1400
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610818301740